Cargando…

Circulating Tumour Cell Associated MicroRNA Profiles Change during Chemoradiation and Are Predictive of Response in Locally Advanced Rectal Cancer

SIMPLE SUMMARY: A standard treatment for locally advanced rectal cancer consists of trimodality therapy of neoadjuvant radiation +/− chemotherapy, surgery, and adjuvant chemotherapy. There is a need for biomarkers to predict treatment response and outcome with the aim of personalizing patient treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Stephanie H., Chua, Wei, Ng, Weng, Ip, Emilia, Marques, Tania M., Tran, Nham T., Gama-Carvalho, Margarida, Asghari, Ray, Henderson, Christopher, Ma, Yafeng, de Souza, Paul, Spring, Kevin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452825/ https://www.ncbi.nlm.nih.gov/pubmed/37627212 http://dx.doi.org/10.3390/cancers15164184

Ejemplares similares

Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic Disparities
por: Lim, Stephanie Hui-Su, et al.
Publicado: (2019)

Developing a virus-microRNA interactome using cytoscape
por: Hill, Meredith, et al.
Publicado: (2019)

Fasciola hepatica hijacks host macrophage miRNA machinery to modulate early innate immune responses
por: Tran, Nham, et al.
Publicado: (2021)

The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer
por: Palma, Pablo, et al.
Publicado: (2010)

The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma
por: Buka, David, et al.
Publicado: (2017)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019)

Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer
por: Gómez del Pulgar, Teresa, et al.
Publicado: (2016)

Change of telomerase activity in rectal cancer with chemoradiation therapy.
por: Kim, H. R., et al.
Publicado: (2000)

Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
por: Conde-Muíño, Raquel, et al.
Publicado: (2015)

Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021)

Network Approaches to Study Endogenous RNA Competition and Its Impact on Tissue-Specific microRNA Functions
por: Marques, Tânia Monteiro, et al.
Publicado: (2022)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Evaluation of Changes in Circulating Cell-Free DNA as an Early Predictor of Response to Chemoradiation in Rectal Cancer—A Pilot Study
por: Ong, Wee Liam, et al.
Publicado: (2023)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety
por: Peponi, Evangelia, et al.
Publicado: (2015)

Rectal tumor fragmentation as a response pattern following chemoradiation
por: Mills, Matthew N., et al.
Publicado: (2022)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer
por: Hinz, Sebastian, et al.
Publicado: (2015)

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial
por: Verstraete, M, et al.
Publicado: (2015)

Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer
por: Bitterman, Danielle S., et al.
Publicado: (2015)

Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
por: Lombardi, Raffaele, et al.
Publicado: (2009)

Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
por: Restivo, Angelo, et al.
Publicado: (2015)

Predictive clinical model of tumor response after chemoradiation in rectal cancer
por: Santos, Marisa D, et al.
Publicado: (2017)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2017)

Anterior abdominal wall metastasis following curative resection and chemoradiation of rectal cancer masquerading as a desmoid tumour: A clinical conundrum
por: Raveendranadh, Ajay, et al.
Publicado: (2021)

Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen
por: Habr-Gama, Angelita, et al.
Publicado: (2016)

Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer
por: Lee, Yong Joon, et al.
Publicado: (2018)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
por: Ott, Oliver J., et al.
Publicado: (2021)

Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2021)

Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer
por: Smithson, Mary, et al.
Publicado: (2022)

Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer
por: Chen, Junbing, et al.
Publicado: (2022)

Preoperative MRI accuracy after neoadjuvant chemoradiation for locally advanced rectal cancer
por: Popiţa, Anca-Raluca, et al.
Publicado: (2023)

Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer
por: Jensen, Garrett L., et al.
Publicado: (2023)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Song, Seung Ho, et al.
Publicado: (2021)

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer
por: Thomas, F, et al.
Publicado: (2011)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
por: Jeong, Duck Hyoun, et al.
Publicado: (2013)

Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients
por: Kye, Bong-Hyeon, et al.
Publicado: (2016)

What the radiologist needs to know about restaging of rectal carcinoma after chemoradiation therapy
por: Nazar, ME, et al.
Publicado: (2014)

Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation
por: Wan, Juefeng, et al.
Publicado: (2015)

17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
por: Santos, Marisa D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_utmh1h4gig9h3k78q1a5fq7i4e